Appeal No. 2005-1610 Application No. 10/054,354 Appellants have asserted that a characteristic of the isolated polypeptide and its variants is its ability to bind to an anti-Ehrlichia antibody. Appellants have the burden to show that the introduction of additional components would materially change the characteristics of their invention or whether such components are excluded from their claims. In re De Lajarte, 337 F.2d 870, 143 USPQ 256 (CCPA 1964). Appellants have not met this burden. Appellants have not shown that whole Ehrlichia proteins encompassed by the claim scope do not have the ability to bind to an anti-Ehrlichia antibody, a characteristic of the sequence and sequence variants appellants have claimed. Appellants have not recited a specific sensitivity and/or specificity for the polypeptide of SEQ ID NO:1 in the claims to distinguish the claimed sequence from whole Erhlichia proteins. We decline to import limitations from the specification that are not part of the claim into the claims before us, as requested by appellants. The Request for Reconsideration is denied. CONCLUSION Therefore, the request for reconsideration is denied. 4Page: Previous 1 2 3 4 5 6 NextLast modified: November 3, 2007